// App-Quantinova.ai

: Heterogeneity and time course of asthma exacerbations: data from AUSTRI

Researchers

Presenter

  • Helen K Reddel

Principal Investigators

  • William Busse

  • Klaus F Rabe

  • Bhumika Aggarwal

  • Richard Forth

  • Isabelle Boucot

  • Ibrahim Raphiou

  • David Stempel

Medical Centers

  • University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, United States

  • GlaxoSmithKline, Singapore, Singapore

  • LungenClinic Grosshansdorf, Grosshansdorf, Germany

  • GlaxoSmithKline, Research Triangle Park, Durham, United States of America

  • Glaxo-Smith Kline, Brentford, London, United Kingdom

  • Propeller Health, San Francisco, United States of America

  • Woolcock Institute of Medical Research, University of Sydney, Sydney, Australia.

Locations

  • United States

  • United Kingdom

  • Germany

  • Singapore

  • Australia

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Asthma

Biomarkers

  • N/A

Drug/Treatment

  • Fluticasone propionate

  • Fluticasone furoate

  • Salmeterol Xinafoate

Outcome

  • N/A

Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved